Trends in Patient Reported Outcomes of Conservative and Surgical Treatment of Primary Chronic Venous Disease Contradict Current Practices  by Lurie, F. & Kistner, R.L.
t
r
f
e
b
p
r
8
l
1
c
r
f
(
s
t
w
a
b
p
T
f
W
s
a
p
(
T
T
P
L
t
R
f
v
f
t
f
o
f
h
a
u
r
p
a
t
1
m
c
O
Q
r
8
t
p
p
(
c
m
t
r
4
r
v
o
b
p
t
JOURNAL OF VASCULAR SURGERY
November 20111536 AbstractsAAAs. There were 28 deaths (6.1%) following elective repair of 459 inciden-
tally detected AAAs (OR, 0.37; 0.24 to 0.68).
Comment: The risk of death in a male patient 65 years operated for
an incidentally detected aneurysm is approximately three times more than
one operated on for a screened detected AAA. The data do not permit a
“drill down” for why patients operated on for screened AAAs have lower
operative mortality than those operated on for incidentally detected AAAs.
Reasons could include lower ages and decreased comorbidities of screened
patients. Also, screened patients may have smaller aneurysms and/or less
complex anatomy permitting a higher proportion of endovascular repairs.
Overall, however, the author’s data provid another bit of evidence to
encourage screening in patients at risk at for AAA.
Proposed Chronic Cerebrospinal Venous Insufficiency Criteria DoNot
Predict Multiple Sclerosis Risk or Severity
Centonze D, Floris R, Stefanini M, et al. Ann Neurol 2011;70:51-8.
Conclusion: Chronic cerebrospinal venous insufficiency (CCSVI) has
no role in either multiple sclerosis (MS) risk or MS severity.
Summary: Anatomic abnormalities of major neck and chest veins are
proposed to impair central nervous system venous drainage. Zamboni has
proposed that CCSVI has a strong association withmultiple sclerosis (J Neu-
rol Neurosurg Psychiatry 2009;80:382-99). His results indicate MS is
caused by CCSVI and that CCSVI plays a substantial role inMS progression.
Endovascular interventions directed to correct abnormalities of venous
drainage reportedly characteristic of CCSVI could potentially improve the
clinical course of MS (Zamboni P, et al. J Vasc Surg 2009;50:1348-58).
However, some question the very existence of CCSVI (Doepp F et al. Ann
Neurol 2010;68:173-83).
It has been suggested that studies failing to demonstrate a significant
association between CCSVI and MS use alternative approaches to define
CCSVI than those utilized by Zamboni et al. The authors, therefore, utilized
an experimental protocol they feel is identical to that developed by Zamboni
and coworkers. This protocol was applied to an independent population of
MS patients and healthy controls by operators specifically trained by Dr
Zamboni in CCSVI identification.
The Zamboni method for CCSVI identification was studied in 84 MS
patients and 56 healthy subjects. There were no significant differences (P 
.12) in CCSVI frequency between MS and control subjects. No differences
were found between CCSVI-positive and CCSVI-negative patients with
respect to MS duration, time between MS onset and first relapse, relapsing
progressive MS, and risk of secondary progression. There were no statistical
differences found between CCSVI-positive and CCSVI-negative MS sub-
jects by analyzingmeasures of disability such as the mean expanded disability
status scale (P .07) mean progressive index (P .1) and meanMS severity
score (P  .1). The percentage of subjects who reached expanded disability
status scale 4.0 and 6.0 was not different among CCSVI-negative and
CCSVI-positive patients. There was no difference found between severity of
disability and number of positive CCSVI criteria.
Comment: This paper disputes the Zamboni theory of CCSVI as the
etiology of MS. By using ultrasound operators specifically trained by Zam-
boni, the authors sought to dissuade the arguments utilized to criticize
previous negative studies as being secondary to inappropriate operator
training or skills. The results here, put simply, do not support a role of
venous abnormalities in MS. It is still premature and, in many respects,
perhaps irresponsible to offer endovascular procedures to correct CCSVI in
the MS patient population.
Symptomatic Internal Carotid Artery Occlusion: A Long-Term Fol-
low-Up Study
Persoon S, Luitse MJA, de Borst G, et al. J Neurol Neurosurg Psychiatry
2011;82:521-6.
Conclusion: In patients with minor stroke or transient ischemic attack
(TIA) and internal carotid artery (ICA) occlusion, recurrent ischemic stroke
is infrequent compared to other vascular events and is dependent upon
clinical factors and the presence of leptomeningeal collaterals.
Summary: In the short- to medium-term, patients with TIA or stroke
associated with occlusion of the ICA appear to have a risk of recurrent stroke
of approximately 5% per year (Klijn CJM, et al. Cebrovas Dis 2001;12:228-
34). The authors previously reported short-term data on prognosis of
patients with symptomatic ICA occlusion with respect to hemodynamic
compromise of the ICA distribution ( Klijn CJM, et al. Neurology 2000;55:
1806-12). The current study represents long-term data of this original
cohort with respect to hemodynamic characteristics of the brain and risk of
ischemic stroke.
There were 117 consecutive patients with TIAs or moderately disabling
cerebral or retinal ischemia associated with ICA occlusion entered into the
study between September 1995 and July 1998 and followed until June
2008. The risk of recurrent ischemic stroke and other vascular events was
analyzed. These variables were analyzed with respect to potentially prognos-
c
sic factors, including collateral pathways and transcranial Doppler CO2
eactivity.
The mean age of the patients was 61 9 years; 80% were male. Median
ollow-up was 10.2 years. Twenty-two patients underwent carotid endarter-
ctomy for contralateral ICA stenosis and 16 had extracranial/intracranaial
ypass surgery. Twenty-three patients had recurrent ischemic stroke com-
uting to an annual rate of 2.4% (95% CI, 1.5 to 3.6). Risk factors for
ecurrent ischemic stroke were cerebral rather than retinal symptoms (HR,
.0; 1.0260), recurrent symptoms after ICA occlusion (HR, 4.4; 1.6 to 12),
imb-shaking TIAs at presentation (HR, 7.5; 2.6 to 22), age (HR, 1.07;
.02 to 1.13), history of stroke (HR, 2.8;1.2 to 6.7), and leptomeningeal
ollaterals (HR, 5.2; 1.5 to 17). CO2 reactivity was not a risk factor for
ecurrent ischemic stroke (HR, 1.01; 0.99 to 1.02). Vascular events in
ollow-up were frequent and occurred in 57 patients for annual rate of 6.4%
95% CI, 4.9 to 8.2).
Comment: The medical arm of the EC/IC bypass trial (EC/IC bypass
tudy group. NEJM 1985;313:1191-200) is the largest cohort of medically
reated patients with symptomatic ICA occlusion. Follow-up in that study
as 4.5 years and the mean annual risk of ischemic stroke was 6.3%. The
uthors lower observed risk of recurrent ischemic stroke may be related to
etter medical management than in the 1980s. Also, inclusion of a larger
ercentage of patients with retinal symptoms may have lowered overall risk.
he high rate of other vascular events in patients with ICA occlusion argues
or aggressive management of atherosclerotic risk factors in these pateints.
hile leptomeningeal collaterals appear predictive of recurrent ischemic
troke, it is not suggested that with patients ICA occlusion undergo routine
ngiography. Whether or not EC/IC bypass surgery will prevent stroke in
atients with hemodynamic compromise is currently under investigation
GRUBB, RL Jr, et al Neurosurg Focus 2003;14:e9).
rends in Patient Reported Outcomes of Conservative and Surgical
reatment of Primary Chronic Venous Disease Contradict Current
ractices
urie F, Kistner RL. Ann Surg 2011;254:363-7.
Conclusion: For patients with primary chronic venous disease, surgical
reatment provides better symptom relief compared to conservative therapy.
elief of symptoms after conservative therapy predicts better outcomes
ollowing surgical treatment.
Summary: Many insurance policies will only approve treatment for
aricose veins when medically necessary, with medical necessity defined as
ailure to obtain symptom relief with conservative management. Conserva-
ive management is generally the use of a graduated compression stockings
or 1 to 6 months. There is, however, no evidence that conservative therapy
bviates further improvement with surgical treatment. The potential of
urther improvement in symptoms with surgical therapy for patients who
ave improved with conservative therapy is not known. In assessing the
ffects of conservative therapy of chronic venous disease, few studies have
tilized patient-reported outcomes. Patient-centered medicine, in essence,
equires examination of practice guidelines and polices from the patient
erspective of treatment outcomes.
The purpose of this study was to analyze patient reported quality of life
nd symptoms in a cohort of chronic venous disease patients managedwithin
he framework of existing policies. This was a prospective cohort study of
50 patients with C2-C4 primary chronic venous disease. Initial manage-
ent included conservative measures, following which patients were given a
hoice of continuing conservative therapy, or moving on to surgical therapy.
ne and 12 month follow-up visits were scheduled after surgical therapy.
uality of life (QOL) scores and symptom score (SS) were analyzed sepa-
ately. Conservative treatment provided improvement of symptom scores in
5 (57% of patients) and in QOL scores in 111 (74%) patients. Even though
he majority of patients improved, 121 elected surgical treatment after a
eriod of conservative therapy. One month after surgical treatment, 80% of
atients (n 97) had further significant improvement of symptoms and 114
94%) had further improvement in QOL scores compared to their after
onservative therapy period. Improvements in the QOL scores were due
ainly to improvements in symptoms. If patients improved after conserva-
ive therapy, they were more than 15 times more likely to have symptom
elief at 1 month following surgical therapy (relative risk  15.6; 95%CI,
.3-56.5) and at 1 year were 21 timesmore likely to have improved symptom
elief following surgery (relative risk  21.3; 95%CI, 4.7-96.9).
Comment: Conservative therapy for patients with primary chronic
enous disease improves symptoms and quality of life. The provocative piece
f this paper is to suggest improvement with conservative therapy should not
e used to withhold surgical therapy, but actually serves as a marker for
atients who will improve further with surgical therapy. The findings con-
radict the present practice of insurance companies interpreting success of
onservativemeasures as a contraindication to surgical treatment. In essence,
uccess of conservative therapy arguably is an indication for surgical therapy.
